Stefanie Pluschkell - Groton CT, US Roderick Geldart - West Kingston RI, US Lewis Ho - Waterford CT, US Mark Koehler - Gaithersburg MD, US Centenary Okediadi - Franklin CT, US Stephen Pias - Gales Ferry CT, US Marie Zhu - East Lyme CT, US Steven Hawrylik - N.Stonington CT, US Matthew Moyle - Houston MA, US
International Classification:
C12P021/02 C12N005/06 C07K014/475
US Classification:
435/069100, 435/320100, 435/325000, 530/397000
Abstract:
The present invention relates to a method for the preparation of a Neutrophil Inhibitory Factor (NIF) comprising the cultivation of mammalian cells expressing NIF in an animal component-free growth medium. The present invention may be employed in large-scale preparation of NIF. The invention also relates to a method for the preparation of recombinant proteins comprising the cultivation of mammalian cells expressing an exogenous recombinant protein in an animal component-free growth medium.
Process For The Preparation Of Neutrophil Inhibitory Factor
Stefanie Pluschkell - Mystic CT, US Roderick Geldart - West Kingston RI, US Lewis Ho - Waterford CT, US Mark Koehler - Germantown MD, US Centy Okediadi - Franklin CT, US Stephen Pias - Gales Ferry CT, US Marie Zhu - East Lyme CT, US Steven Hawrylik - North Stonington CT, US
International Classification:
C12P021/02 C12N009/99
US Classification:
530/395000, 435/069200, 435/184000
Abstract:
The present invention relates to a method for the preparation of a Neutrophil Inhibitory Factor (NIF) comprising the cultivation of mammalian cells expressing NIF in an animal component-free growth medium. The present invention may be employed in large-scale preparation of NIF. The invention also relates to a method for the preparation of recombinant proteins comprising the cultivation of mammalian cells expressing an exogenous recombinant protein in an animal component-free growth medium.